We are live on ! Find out more
GFM

GF Fund Management Portfolio holdings

AUM $5.98B
1-Year Est. Return 80.99%
This Fund
S&P 500
This Quarter Est. Return
+11.47%
1 Year Est. Return
+80.99%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$5.98B
AUM Growth
+$132M
Cap. Flow
+$20.2M
Cap. Flow %
0.34%
Top 10 Hldgs %
41.51%
Holding
666
New
23
Increased
324
Reduced
223
Closed
42

Top Buys

Rank Stock Value
1
WMT icon
Walmart Inc
WMT
+$142M
2
ASML icon
ASML
ASML
+$117M
3
TSEM icon
Tower Semiconductor
TSEM
+$112M
4
LRCX icon
Lam Research
LRCX
+$88M
5
MU icon
Micron Technology
MU
+$53.9M

Top Sells

Rank Stock Value
1
SNDK
Sandisk
SNDK
+$81.3M
2
LITE icon
Lumentum
LITE
+$72.3M
3
PM icon
Philip Morris
PM
+$40M
4
MSFT icon
Microsoft
MSFT
+$28.5M
5
META icon
Meta Platforms (Facebook)
META
+$27.2M

Sector Composition

Rank Sector Weight
1 Technology 54.47%
2 Communication Services 12.44%
3 Consumer Discretionary 11.77%
4 Consumer Staples 6.03%
5 Healthcare 5.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CCCC icon
601
C4 Therapeutics
CCCC
$396M
$5.69K ﹤0.01%
2,165
+262
+14% +$617
SLN
602
Silence Therapeutics
SLN
$495M
$5.52K ﹤0.01%
1,047
+125
+14% +$688
EDIT icon
603
Editas Medicine
EDIT
$442M
$5.37K ﹤0.01%
2,174
+263
+14% +$557
OBIO icon
604
Orchestra BioMed
OBIO
$222M
$5.36K ﹤0.01%
1,260
+151
+14% +$643
VYGR icon
605
Voyager Therapeutics
VYGR
$184M
$5.17K ﹤0.01%
1,339
+161
+14% +$634
ARCT icon
606
Arcturus Therapeutics
ARCT
$170M
$5.04K ﹤0.01%
653
+76
+13% +$555
OABI icon
607
OmniAb
OABI
$302M
$5.03K ﹤0.01%
3,201
+373
+13% +$673
HPP
608
Hudson Pacific Properties
HPP
$800M
$4.96K ﹤0.01%
840
-69
-8% -$530
BCYC
609
Bicycle Therapeutics
BCYC
$290M
$4.79K ﹤0.01%
1,032
+123
+14% +$703
CHRS icon
610
Coherus Oncology
CHRS
$219M
$4.59K ﹤0.01%
2,714
+413
+18% +$733
CRBU icon
611
Caribou Biosciences
CRBU
$161M
$3.99K ﹤0.01%
2,099
+264
+14% +$453
MENS
612
Jyong Biotech
MENS
$172M
$3.61K ﹤0.01%
1,677
+184
+12% +$450
SGMT icon
613
Sagimet Biosciences
SGMT
$442M
$3.6K ﹤0.01%
689
+81
+13% +$451
TKNO icon
614
Alpha Teknova
TKNO
$284M
$3.45K ﹤0.01%
1,194
+143
+14% +$403
LFCR icon
615
Lifecore Biomedical
LFCR
$176M
$3.11K ﹤0.01%
836
+100
+14% +$690
CDXS icon
616
Codexis
CDXS
$201M
$2.95K ﹤0.01%
1,808
+33
+2% +$47
QSI icon
617
Quantum-Si Incorporated
QSI
$178M
$2.88K ﹤0.01%
3,723
– –
PEPG icon
618
PepGen
PEPG
$152M
$2.71K ﹤0.01%
1,533
+183
+14% +$1.03K
BDTX icon
619
Black Diamond Therapeutics
BDTX
$104M
$2.71K ﹤0.01%
1,272
+153
+14% +$364
HUMA icon
620
Humacyte
HUMA
$177M
$2.55K ﹤0.01%
4,203
+638
+18% +$663
PYXS icon
621
Pyxis Oncology
PYXS
$143M
$1.92K ﹤0.01%
1,316
+39
+3% +$59
AARD
622
Aardvark Therapeutics
AARD
$121M
$1.82K ﹤0.01%
483
+56
+13% +$581
GOSS icon
623
Gossamer Bio
GOSS
$68.9M
$1.7K ﹤0.01%
5,173
+626
+14% +$984
RANI icon
624
Rani Therapeutics
RANI
$77.1M
$1.6K ﹤0.01%
2,175
+318
+17% +$406
AFRM icon
625
Affirm
AFRM
$25.2B
– –
-24,491
Closed -$1.82M
23 24
25
26 27

Similar funds

CM
CastleKnight Management New York $6B AUM 121.87% 1-Year Est. Return
BP
BC Partners New York $5.96B AUM 15.21% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
CAG
Crestwood Advisors Group Boston, Massachusetts $5.94B AUM 18.44% 1-Year Est. Return
WHRC
W.H. Reaves & Co Jersey City, New Jersey $6.03B AUM 40.55% 1-Year Est. Return
RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
AL
Appaloosa LP Short Hills, New Jersey $5.93B AUM 44.55% 1-Year Est. Return
CGPCS
Capital Group Private Client Services Los Angeles, California $5.93B AUM 27.73% 1-Year Est. Return

GF Fund Management's Q1 2026 Portfolio in Review

As of Q1 2026, GF Fund Management held 666 positions worth $5.98B, up 2.3% from $5.85B the previous quarter. Its ten largest holdings account for 42% of the portfolio.

GF Fund Management's Q1 2026 filing shows 23 new, 324 increased, 223 reduced and 42 closed positions. Its largest new stake was Coherent: 98,000 shares worth $23.3M. The largest sale was Sandisk, an estimated $81.3M.

By sector, the portfolio is most concentrated in Technology at 54% of assets, up from 51% a quarter earlier, followed by Communication Services and Consumer Discretionary.

  • GF Fund Management's largest Q1 2026 buy was Coherent: 98,000 shares worth $23.3M.
  • GF Fund Management added most to Walmart Inc in Q1 2026, an estimated $142M increase.
  • GF Fund Management's biggest Q1 2026 reduction was Sandisk, cutting an estimated $81.3M.
  • GF Fund Management fully exited AstraZeneca in Q1 2026, selling an estimated $12.4M.
  • GF Fund Management's ten largest holdings make up 42% of its $5.98B portfolio in Q1 2026.
  • GF Fund Management opened 23 new positions and closed 42 in Q1 2026.
  • GF Fund Management's portfolio value rose 2.3% quarter-over-quarter to $5.98B.

Based on GF Fund Management's 13F filing for Q1 2026, filed 15 Apr 2026.